While big pharma have tried many things, including tapping smaller biotech firms and outsourcing R&D, trying something new like starting over is notable. Merck, Pfizer, and Eli Lilly have gotten funding to launch Enlight Biosciences, a company that will focus on previously ignored technologies and work to "smooth out the transition from animal testing to human testing that often puts a kink in the discovery process," says a Forbes article.